Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

Despite its increased recognition as a major health threat, fatty liver disease associated with
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …

Non‐alcoholic fatty liver disease (NAFLD) affects at least 25% of the general population and
is an increasingly important cause of cirrhosis and hepatocellular carcinoma. Although it is …

The metabolic syndrome as a consequence of the obesity pandemic resulted in a
substantial increase in the prevalence of metabolic-associated fatty live disease (MAFLD) …

The mechanisms of fatigue in the group of people with non-alcoholic fatty liver disease and
non-alcoholic steatohepatitis are protean. The liver is central in the pathogenesis of fatigue …

Background Non-alcoholic fatty liver disease (NAFLD) was previously a neglected disease
that is now becoming a worldwide pandemic. A better understanding of its incidence and …

Fatty liver disease associated with metabolic dysfunction is the most prevalent liver disease
worldwide, though both patient and health professional still lack awareness of it. An …

Understanding farmers' behavior, motivations, and perceptions toward antimicrobial use can
influence how veterinarians translate research into practice and guide effective ways of …

Purpose To determine whether illness perceptions, coping strategies, and
sociodemographic and clinical variables are related to the quality of life (QoL) in adults with …